Ads by Google
Menopause Symptoms Relief
Many medical experts advise taking combination hormone therapy only for short term relief of the symptoms of menopause.
As they transition to menopause, women with no history of depression may be at an increased risk of new onset depressive symptoms and disorders.
A single dose of depomedroxyprogesterone acetate (MPA) more effectively reduces hot flashes than does the antidepressant venlafaxine.
Regular physical activity and a balanced diet can help manage many symptoms and health concerns associated with menopause.
Medicines containing the female hormones estrogen and progestin are highly effective at reducing the symptoms of menopause, but risks outweigh the benefits for most women.
The addition of testosterone to hormone therapy in women after menopause enhances their sexual function.
While some women experience no menopausal symptoms, others suffer severe symptoms that require treatment.
September is National Menopause Awareness Month. Alleviate menopause symptoms with these menopause hormone therapy guidelines.
Women experience accelerated bone loss at a rate of three to five percent per year for about five to seven years after menopause.
Over half of women who began menopausal hormone therapy because of symptoms such as hot flashes or night sweats experience those symptoms when they discontinue hormone therapy.
Diminished sexual desire has been reported by 30 to 50 percent of women who undergo surgical menopause, menopause induced by the surgical removal of both ovaries.
The study helps the researchers to assess drugs or nutraceuticals that may reduce the bone loss that sets in with menopause.
Estrogen deficiency after menopause and consequent loss of bone mineral density have been shown to be associated with increased rate of tooth loss.
Even in low doses estrogen prevents bone loss at menopause in the vast majority of women.
Some women who use a combination of estrogen and progestin to control the symptoms of menopause might find symptoms return when they stop the hormones.
Short term hormone replacement therapy (HRT) is appropriate for peri and postmenopausal women.
Experts recommens over the counter dietary supplements among the first lines of defense in the treatment of the symptoms of menopause.Treatment of Menopause Symptoms
Eight internationally renowned women's health experts, lead by Lila Nachtigall, MD, recommend over-the- counter dietary supplements among the first lines of defense in the treatment of the symptoms of menopause.
NCCTG Study Compares Venlafaxine and Progestational Agents in Reducing Hot Flashes: A Menopause Symptom
The trial demonstrated that a single dose of medroxyprogesterone acetate (MPA), alleviated hot flashes (menopause symptom) more than did the daily use of the oral antidepressant venlafaxine (Effexor).
The findings should help to look for other methods that can help control the common symptoms of menopause.
The Task Force did not examine the combined estrogen and progestin for the treatment of menopausal symptoms, only for the prevention of chronic disease.
The expanding waistline and increasing cholesterol levels many women face after menopause may be a factor in the stiffening of their arteries.
An exercise program during and after menopause should include weight bearing and resistance exercise to help increase or maintain bone density and prevent osteoporosis.
Women not experiencing severe symptoms of menopause should simply wait out their bodily changes without the help of hormone replacement therapy (HRT).
A National Institutes of Health consensus panel announced on March 24th that women not experiencing severe symptoms of menopause should simply wait out their bodily changes without the help of hormone replacement therapy (HRT).
The future research direction for the treatment of menopausal symptoms is multifaceted. Cross national studies of menopause symptoms and their management are welcome additions to U.S. data.
Decisionmaking for women regarding treatment of menopausal symptoms requires balancing of potential benefits against potential risks.